Segment disclosures

Company overview

PHARMERICA CORP

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 34 retained observations 12 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Hospital Pharmacy Management

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pmc:HospitalPharmacyManagementMember
PeriodValueUnitFiledEvidence
2013-10-01 – 2013-12-310 USD20140228Open filing evidence
2013-07-01 – 2013-09-300 USD20140228Open filing evidence
2013-04-01 – 2013-06-300 USD20140228Open filing evidence
2013-01-01 – 2013-03-310 USD20140228Open filing evidence
2012-10-01 – 2012-12-3120200000 USD20140228Open filing evidence
2012-07-03 – 2012-09-3015800000 USD20121101Open filing evidence
2012-07-01 – 2012-09-3015800000 USD20140228Open filing evidence
2012-01-01 – 2012-09-3048100000 USD20121101Open filing evidence
2012-04-01 – 2012-06-3016200000 USD20140228Open filing evidence
2012-01-01 – 2012-06-3032300000 USD20120802Open filing evidence
2012-01-01 – 2012-03-3116100000 USD20140228Open filing evidence
2011-10-01 – 2011-12-3115600000 USD20130207Open filing evidence
2011-07-01 – 2011-09-3015700000 USD20130207Open filing evidence
2011-01-01 – 2011-09-3046900000 USD20121101Open filing evidence
2011-04-01 – 2011-06-3015700000 USD20130207Open filing evidence
2011-01-01 – 2011-06-3031200000 USD20120802Open filing evidence
2011-01-01 – 2011-03-3115500000 USD20130207Open filing evidence

Institutional Pharmacies

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=pmc:InstitutionalPharmaciesMember
PeriodValueUnitFiledEvidence
2013-10-01 – 2013-12-310 USD20140228Open filing evidence
2013-07-01 – 2013-09-300 USD20140228Open filing evidence
2013-04-01 – 2013-06-300 USD20140228Open filing evidence
2013-01-01 – 2013-03-310 USD20140228Open filing evidence
2012-10-01 – 2012-12-31413000000 USD20140228Open filing evidence
2012-07-03 – 2012-09-30426200000 USD20121101Open filing evidence
2012-07-01 – 2012-09-30426200000 USD20140228Open filing evidence
2012-01-01 – 2012-09-301351300000 USD20121101Open filing evidence
2012-04-01 – 2012-06-30442300000 USD20140228Open filing evidence
2012-01-01 – 2012-06-30925100000 USD20120802Open filing evidence
2012-01-01 – 2012-03-31482800000 USD20140228Open filing evidence
2011-10-01 – 2011-12-31480000000 USD20130207Open filing evidence
2011-07-01 – 2011-09-30503000000 USD20130207Open filing evidence
2011-01-01 – 2011-09-301538600000 USD20121101Open filing evidence
2011-04-01 – 2011-06-30516000000 USD20130207Open filing evidence
2011-01-01 – 2011-06-301035600000 USD20120802Open filing evidence
2011-01-01 – 2011-03-31519600000 USD20130207Open filing evidence